290 related articles for article (PubMed ID: 37894282)
1. Hsa-miR-665 Is a Promising Biomarker in Cancer Prognosis.
Guan X; Pavani KC; Chunduru J; Broeckx BJG; Van Soom A; Peelman L
Cancers (Basel); 2023 Oct; 15(20):. PubMed ID: 37894282
[TBL] [Abstract][Full Text] [Related]
2. Determination of Common microRNA Biomarker Candidates in Stage IV Melanoma Patients and a Human Melanoma Cell Line: A Potential Anti-Melanoma Agent Screening Model.
Antonova E; Hambikova A; Shcherbakov D; Sukhov V; Vysochanskaya S; Fadeeva I; Gorshenin D; Sidorova E; Kashutina M; Zhdanova A; Mitrokhin O; Avvakumova N; Zhernov Y
Int J Mol Sci; 2023 May; 24(11):. PubMed ID: 37298110
[TBL] [Abstract][Full Text] [Related]
3. Principal component analysis based feature extraction approach to identify circulating microRNA biomarkers.
Taguchi YH; Murakami Y
PLoS One; 2013; 8(6):e66714. PubMed ID: 23874370
[TBL] [Abstract][Full Text] [Related]
4. miR-638: A Promising Cancer Biomarker with Therapeutic Potential.
Hasheminasabgorji E; Mishan MA; Tabari MAK; Bagheri A
Curr Mol Med; 2023; 23(5):377-389. PubMed ID: 35382724
[TBL] [Abstract][Full Text] [Related]
5. The role of miRNAs in regulation of platelet activity and related diseases - a bioinformatic analysis.
Wicik Z; Czajka P; Eyileten C; Fitas A; Wolska M; Jakubik D; von Lewinski D; Sourij H; Siller-Matula JM; Postula M
Platelets; 2022 Oct; 33(7):1052-1064. PubMed ID: 35285386
[TBL] [Abstract][Full Text] [Related]
6. Analysis of microRNA (miRNA) expression profiles reveals 11 key biomarkers associated with non-small cell lung cancer.
Wang K; Chen M; Wu W
World J Surg Oncol; 2017 Sep; 15(1):175. PubMed ID: 28927412
[TBL] [Abstract][Full Text] [Related]
7. MicroRNAs: potential biomarkers for diagnosis and prognosis of different cancers.
Sharma PC; Gupta A
Transl Cancer Res; 2020 Sep; 9(9):5798-5818. PubMed ID: 35117940
[TBL] [Abstract][Full Text] [Related]
8. Small RNA sequencing identified miR-3180 as a potential prognostic biomarker for Chinese hepatocellular carcinoma patients.
Sun L; Zhou H; Zhao X; Zhang H; Wang Y; Li G
Front Genet; 2023; 14():1102171. PubMed ID: 37051592
[TBL] [Abstract][Full Text] [Related]
9. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
Zeng Y; Wang KX; Xu H; Hong Y
J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
[TBL] [Abstract][Full Text] [Related]
10. Atrophic gastritis and gastric cancer tissue miRNome analysis reveals hsa-miR-129-1 and hsa-miR-196a as potential early diagnostic biomarkers.
Varkalaite G; Vaitkeviciute E; Inciuraite R; Salteniene V; Juzenas S; Petkevicius V; Gudaityte R; Mickevicius A; Link A; Kupcinskas L; Leja M; Kupcinskas J; Skieceviciene J
World J Gastroenterol; 2022 Feb; 28(6):653-663. PubMed ID: 35317427
[TBL] [Abstract][Full Text] [Related]
11. Determination of Dysregulated miRNA Expression Levels by qRT-PCR after the Application of Usnic Acid to Breast Cancer.
Tanman Ü; Yangın S; Cansaran-Duman D
Anticancer Agents Med Chem; 2020; 20(5):548-558. PubMed ID: 31549595
[TBL] [Abstract][Full Text] [Related]
12. Potential role of miR-100 in cancer diagnosis, prognosis, and therapy.
Qin C; Huang RY; Wang ZX
Tumour Biol; 2015 Mar; 36(3):1403-9. PubMed ID: 25740059
[TBL] [Abstract][Full Text] [Related]
13. A Systematic Review of MicroRNA Expression as Biomarker of Late-Onset Alzheimer's Disease.
Herrera-Espejo S; Santos-Zorrozua B; Álvarez-González P; Lopez-Lopez E; Garcia-Orad Á
Mol Neurobiol; 2019 Dec; 56(12):8376-8391. PubMed ID: 31240600
[TBL] [Abstract][Full Text] [Related]
14. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside.
Grieco GE; Besharat ZM; Licata G; Fignani D; Brusco N; Nigi L; Formichi C; Po A; Sabato C; Dardano A; Natali A; Dotta F; Sebastiani G; Ferretti E
Transl Res; 2022 Sep; 247():137-157. PubMed ID: 35351622
[TBL] [Abstract][Full Text] [Related]
15. Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.
Song J; Ouyang Y; Che J; Li X; Zhao Y; Yang K; Zhao X; Chen Y; Fan C; Yuan W
Front Immunol; 2017; 8():56. PubMed ID: 28261196
[TBL] [Abstract][Full Text] [Related]
16. Dynamic monitoring of circulating microRNAs as a predictive biomarker for the diagnosis and recurrence of papillary thyroid carcinoma.
Zhang Y; Xu D; Pan J; Yang Z; Chen M; Han J; Zhang S; Sun L; Qiao H
Oncol Lett; 2017 Jun; 13(6):4252-4266. PubMed ID: 28599426
[TBL] [Abstract][Full Text] [Related]
17. Circular RNA hsa_circ_0004872 inhibits gastric cancer progression via the miR-224/Smad4/ADAR1 successive regulatory circuit.
Ma C; Wang X; Yang F; Zang Y; Liu J; Wang X; Xu X; Li W; Jia J; Liu Z
Mol Cancer; 2020 Nov; 19(1):157. PubMed ID: 33172486
[TBL] [Abstract][Full Text] [Related]
18. Identification of circulating miRNAs as novel prognostic biomarkers for bladder cancer.
Lin GB; Zhang CM; Chen XY; Wang JW; Chen S; Tang SY; Yu TQ
Math Biosci Eng; 2019 Nov; 17(1):834-844. PubMed ID: 31731380
[TBL] [Abstract][Full Text] [Related]
19. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal miR-1269a serves as a diagnostic marker and plays an oncogenic role in non-small cell lung cancer.
Wang X; Jiang X; Li J; Wang J; Binang H; Shi S; Duan W; Zhao Y; Zhang Y
Thorac Cancer; 2020 Dec; 11(12):3436-3447. PubMed ID: 33107700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
